MENQUADFI

Approval Id: 6a274064acd588dd
Drug Approval Canada Name: MENQUADFI
Product Name: MENQUADFI
Status: Marketed
Status Date: 2025-04-01
Original Market Date: 2025-04-01
Din: 02507161
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07AH08 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN CONJUGATED
Atc Name: j 07 ah 08
Aig Number: 0562558001
Company Name: Sanofi Pasteur Limited
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4
Company Detail Path: /organization/b82449f1e6277127/sanofi-pasteur-limited

TETANUS TOXOID

55 MCG / 0.5 ML

MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

10 MCG / 0.5 ML

MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

10 MCG / 0.5 ML

MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

10 MCG / 0.5 ML

MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

10 MCG / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6a274064acd588dd

Type

Standard